Lilly Exec Says Approval Of Mounjaro Multi-Dose Kwikpen In Europe Came In Slightly Ahead Of Co's Expectation Gives Co Additional Confidence In Ability To Launch
禮來公司高管表示,歐洲對Mounjaro多劑量Kwikpen的批准略高於公司的預期,這使公司對上市能力更有信心
Lilly Exec Says Approval Of Mounjaro Multi-Dose Kwikpen In Europe Came In Slightly Ahead Of Co's Expectation Gives Co Additional Confidence In Ability To Launch
禮來公司高管表示,歐洲對Mounjaro多劑量Kwikpen的批准略高於公司的預期,這使公司對上市能力更有信心
使用瀏覽器的分享功能,分享給你的好友吧